Title: Pediatrics – Critical Care: Life-Threatening Infections; Seizures; Flaccid Myelitis
Course ID: PDcc
Michael J. Muszynski, M.D., F.A.A.P.
Professor Emeritus, Department of Clinical Sciences, Florida State University College of Medicine, Faculty Arnold Palmer Hospital for Children
Robert A. Belfer, M.D.
Professor of Clinical Pediatrics, Perelman School of Medicine at the University of Pennsylvania; and Director, Children’s Emergency Department, Children’s Hospital of Philadelphia at Virtua, Voorhees, NJ
Original Release Date: July 1, 2020 Expiration Date: July 1, 2023
TOPIC 1: Life-Threatening Pediatric Infections.
Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP
- Conclude that as newer immunizations eradicate many serious infections, we are still faced with certain pathogens that can cause severe morbidity and mortality.
- Recognize, diagnose and manage the following diseases:
- Toxic Shock Syndrome;
- Rocky Mountain Spotted Fever;
- Kawasaki Syndrome.
- Develop an approach to the patient who presents with fever and a rash.
TOPIC 2: Pediatric Seizures I. Status Epilepticus, II. Febrile Seizures.
Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of
Pediatrics, the participant should be able to: EBM, GL, COMP
- Demonstrate appropriate medications to treat pediatric status epilepticus.
- Utilize the literature concerning epidemiology of febrile seizures in educating patients’ families.
TOPIC 3: Acute Flaccid Myelitis.
Upon completion of this session, the participant should be able to: EBM, GL, COMP
- Recognize the clinical manifestations of AFM and apply the clinical, laboratory, and case classification criteria as defined by the Centers for Disease Control (CDC).
- Compare other known neurological entities in the differential diagnosis of a patient with suspected AFM.
- Recommend appropriate diagnostic testing for AFM and reporting method to health authorities.
- Apply the interim considerations for clinical management of AFM according to the latest expert opinion defined by CDC.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.